Position in VTRS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,189,713
+$471,711 QoQ
Shares Held
74,919
+41.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#300
of 1,022 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 65%
Shared 14%
None 21%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Savant Capital, LLC holds $13,041,183 across 15 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
391,297 | $3,650,801 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
3,845 | $2,083,336 | |
| 3 | VTRS |
Viatris Inc
This page
|
74,919 | $1,189,713 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
15,478 | $989,818 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
56,536 | $906,272 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
5,342 | $900,340 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
7,965 | $883,637 | |
| 8 | ZTS |
Zoetis Inc.
|
9,906 | $711,845 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,189,713 | 74,919 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $718,002 | 53,146 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $356,455 | 28,631 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $242,470 | 24,492 | Shares | Sole | 2026-03-04 | |
| 2025-06-30 | $146,737 | 16,432 | Shares | Sole | 2026-03-04 | |
| 2025-03-31 | $260,838 | 29,947 | Shares | Sole | 2026-03-04 | |
| 2024-12-31 | $526,971 | 42,327 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $469,357 | 40,427 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $403,525 | 37,961 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $470,997 | 39,447 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $447,972 | 41,364 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $383,672 | 38,912 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $343,351 | 34,404 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $262,279 | 27,264 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $254,442 | 22,861 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $110,708 | 12,994 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $152,882 | 14,602 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $144,094 | 13,244 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $155,324 | 11,480 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $151,963 | 11,215 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $151,045 | 10,570 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $153,041 | 10,955 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $214,516 | 11,447 | Shares | Sole | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||